McCall McPhersonFounder, Modern Thyroid Clinic.

GLPs Slash Inflammation: A Health Game-Changer Beyond Weight Loss! #shorts

19 Oct 2026 · 1 min

Watch on YouTube

0:49

In this short commentary, McCall McPherson reports that a single microdose injection of a GLP‑class medication produced a striking drop in high‑sensitivity C‑reactive protein (hs‑CRP), a key marker of systemic inflammation, within just one week. He emphasizes that such a rapid and large reduction would normally require years of lifestyle changes. McPherson argues that lowering inflammation can trigger wide‑ranging benefits for healthspan and lifespan, including reduced risk of cardiovascular disease, cancer, and improved fertility. He predicts that, as clinicians across the country observe these transformative effects, GLP‑based therapies will soon be approved for many indications beyond their current use for weight loss.

Chapters

We have documentation after a week of one microdose with data on their hs-CRP, which is an inflammatory marker. Significant, huge reductions that would take years to reduce with lifestyle modifications in one injection. To me, that is the most powerful thing because that inflammatory reduction then elicits so many other impactful changes for healthspan, for lifespan, for cardiovascular disease, for cancer, for fertility, for all these other aspects of our physiology that I think are on the next frontier of what we can expect for indications for these meds. I think we'll soon see them indicated for so much more than weight loss because the data is everywhere and clinicians around the country are seeing this just simply transform lives.